All In Biotech

Free tool

FAERS Monitor: Ontruzant

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761100 or its brand name (Ontruzant, Trastuzumab-Dttb). Reports on generic versions are filed under their own applications.

Reports

32,364

Serious

30,693

95% of reports

Hospitalization

12,357

Death reported

3,644

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea3,735
  • off label use3,004
  • nausea2,550
  • fatigue2,211
  • myelosuppression1,886
  • vomiting1,743
  • disease progression1,698
  • neutropenia1,608
  • dyspnoea1,388
  • pyrexia1,367
  • anaemia1,311
  • neuropathy peripheral1,225
  • alopecia1,215
  • asthenia1,179
  • ejection fraction decreased1,151

Reports by year received

View as table
YearReports
200425
200539
200613
200780
2008152
2009312
2010444
2011393
2012699
2013841
2014712
2015856
2016810
2017883
20181,716
20192,305
20202,678
20213,141
20223,181
20233,217
20244,185
20253,333
20262,349

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,021,795 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
ejection fraction decreasedSignal1,15151.948.953,177
myelosuppressionSignal1,88635.934.360,628
disease progressionSignal1,6989.49.012,704
neuropathy peripheralSignal1,2258.58.07,990
neutropeniaSignal1,6087.87.49,421
anaemiaSignal1,3114.54.33,562
alopeciaSignal1,2154.03.82,785
diarrhoeaSignal3,7353.83.77,817
pyrexiaSignal1,3672.62.41,331
vomitingSignal1,7432.42.31,470
off label useSignal3,0042.22.22,127
nauseaSignal2,5502.12.01,515
astheniaSignal1,1792.01.9634
fatigue2,2111.81.8890
dyspnoea1,3881.61.5315

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.